|
QuintilesIMS Real-World Insights Bibliography
| The Economic Impact of Overactive Bladder Syndrome in Six Western Countries. |
| Author(s): Irwin DE1, Mungapen L2, Milsom I3, Kopp Z4, Reeves P2, Kelleher C5 |
| Affiliations(s): 1Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC, US 2 IMS Health incorporating Fourth Hurdle Consulting Ltd, London, UK 3 Department of Obstetrics & Gynaecology, Sahlgrenska Academy at the University of Gothenburg, Sweden 4 Pfizer Inc., New York, USA, , 5 Department of Obstetrics and Gynaecology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK |
| Publication(s): British Journal of Urology International (BJU International), 103(2):202-209 |
| Document Type(s): Article |
| Countries: Canada, Germany, Italy, Spain, Sweden, UK |
| Click here for the abstract |
C:
Y: |
Overactive bladder
2009 |
|
L:
A: |
English
Budget impact |
|
 |
| |
| |
| The Toviaz YourWay Plan: A multidimensional program for managing overactive bladder. |
| Author(s): Taylor P1, Trocio J2, Schabert VF3, Golberg EL3, Bavendam T2, Brubaker L4 |
| Affiliations(s): 1 Emory University, Atlanta, GA, USA 2 Pfizer Inc., New York, NY, USA 3 IMS Health, Inc., Falls Church, VA, USA 4 Loyola University, Maywood, IL, USA |
| Publication(s): American Urogynecologic Society 30th Annual Scientific Meeting, 2009, September, Hollywood, FL, USA |
| Document Type(s): Oral presentation |
| Countries: |
C:
Y: |
Overactive bladder
2009 |
|
L:
A: |
English
Review |
|
|
| |
| |
| Challenges for managing overactive bladder and guidance for patient support. |
| Author(s): Schabert VF1, Bavendam T2, GoldbergEL1, Trocio JN2, Brubaker L3 |
| Affiliations(s): 1 IMS Health, Inc., Falls Church, VA, USA 2 Pfizer, Inc., New York, NY, USA 3 Loyola University, Chicago, IL, USA |
| Publication(s): American Journal of Managed Care, 2009, 15(4 Suppl): S118-122 |
| Document Type(s): Article |
| Countries: |
C:
Y: |
Overactive bladder
2009 |
|
L:
A: |
English
Survey research |
|
|
| |
| |
| Dvelopment of a multidimensional approach to managing overactive bladder. |
| Author(s): Taylor P1, Goldberg EL2, Schabert VF2, Trocio J3, Bavendam T3 |
| Affiliations(s): 1 Emory University, Atlanta, GA, USA 2 IMS Health, Inc., Falls Church, VA, USA 3 Pfizer Inc., New York, NY, USA |
| Publication(s): American Academy of Physician Assistants 37th Annual Conference, 2009, May 23-28, San Diego, CA, USA |
| Document Type(s): Poster |
| Countries: |
C:
Y: |
Overactive bladder
2009 |
|
L:
A: |
English
Survey research |
|
|
| |
| |
| Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder. |
| Author(s): Pelletier EM1, Vats V2, Clemens JQ3 |
| Affiliations(s): 1IMS Health, Watertown, MA, USA, 2Pfizer Inc., New York, NY, USA, 3University of Michigan, Ann Arbor, MI, USA |
| Publication(s): American Journal of Managed Care, 2009, 15(Suppl 4): S108-S114 |
| Document Type(s): Manuscript in preparation |
| Countries: USA |
C:
Y: |
Overactive bladder
2009 |
|
L:
A: |
English
Compliance, Cost analysis |
|
|
| |
| |
| Patterns and Predictors of Overactive Bladder-specific Quality of Life. |
| Author(s): Benner J1, Brubaker L, Bavendam T, Fanning F, Goldberg E2, Trocio J3, Jumadilova Z
|
| Affiliations(s): 1 Formerly of IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA 3 Pfizer, New York, NY, US |
| Publication(s): Journal of Pelvic Medicine & Surgery;2007 Sept/Oct;13(5):302-303(#91P) |
| Document Type(s): Manuscript in preparation |
| Countries: USA |
C:
Y: |
Overactive bladder
2008 |
|
L:
A: |
English
Quality of life |
|
|
| |
| |
| “Overactive bladder symptom bother is more prevalent in men than women at older ages.” |
| Author(s): Albo M, Rovner E, Mullins C, Becker R, Jumadilova Z, Benner J. |
| Affiliations(s): |
| Publication(s): American Urology Association Western Section Meeting, October 2006 |
| Document Type(s): Oral presentation |
| Countries: USA |
C:
Y: |
Overactive bladder
2006 |
|
L:
A: |
English
Epidemiological study |
|
|
| |
| |
| “Patient-Reported Reasons for Discontinuing Overactive Bladder (OAB) Medications.” |
| Author(s): Brubaker L, Nichol M, Fanning T, Becker R, Jumadilova Z, Benner J |
| Affiliations(s): |
| Publication(s): Annual International Continence Society Meeting, November 2006. |
| Document Type(s): Abstract |
| Countries: USA |
C:
Y: |
Overactive bladder
2006 |
|
L:
A: |
English
|
|
|
| |
| |
| “Factors Associated with Care Seeking for Overactive Bladder Symptoms,” |
| Author(s): Nichol M, Brubaker L, Fanning T, Hussein M, Becker R, Benner J, Jumadilova Z, |
| Affiliations(s): |
| Publication(s): 11th Annual Meeting of the International Society of Pharmacoeconomics and Outcomes Research, June 2006. |
| Document Type(s): Oral presentation |
| Countries: |
C:
Y: |
Overactive bladder
2006 |
|
L:
A: |
English
|
|
|
| |
| |
|
|
|
